ICOC Application Review Subcommittee Meeting -May

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: May 24^th, 2018
Time: 11:00am to 12:00pm

Main Location

• CIRM 1999 Harrison Street Suite 1650, Oakland, CA 94612

Other Locations:

• 1180 Veterans Blvd, South San Francisco 94080
• 2619 Montclair Street San Diego, CA 92104
• 2007 Redwood Rd., Napa, CA.
• UCLA 10833 Le Conte Avenue, Room 8-684, Los Angeles, CA 90095
• 1500 E. Duarte Road Duarte, CA 91010
• 100 Kimball Way, South San Francisco
• 304 Bowery, New York, NY – Site No Longer Available
• 4005 N. Fresno Street Fresno, CA 93726
• 10996 Torreyana Road, Suite 200 San Diego, CA 92121
• 8170 Laguna Bl, Elk Grove 95758
• 15775 Gum Tree Lane Los Gatos 95032
• 3440 Viking Drive Sacramento, CA 95827
• 1 Dr. Carlton B. Goodlett Place, Room 244 San Francisco, Ca. 94102-4689
• 1426 Lincoln, Calistoga, CA 94515

Dial In and WebEx Information:

• Dial In Number: (800) 230-1093 
  Confirmation Number: 449763 

WebEx Link:

https://cirm.webex.com/cirm/onstage/g.php?MTID=e4fb91d89cfeb56a243b0863a606cbc2c

Conference Cast Link:

• https://im.csgsystems.com/cgi-bin/confCast
• Enter Conference ID# 449763
• Then click Go.

Open Session:

1. Call to Order.
    
2. Roll Call.
    
3. Consideration of applications submitted in response to Clinical Trial Stage Projects (CLIN-1,2 or 3).
   • Clinical Presentation
   • Clinical Portfolio
   • Clin2-10784 Public Summary
4. Consideration of applications submitted in response to Partnering Opportunity: Translational Research Projects.

• Translation Presentation
• Translation Summaries
• Letter to the Board – Tran1 -10958
• Letter to the Board – Tran1 -10958
• Letter to the Board – Tran1 – 10995
• Letter to the Board – Tran1 – 10995

Closed Session:

5. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda items “3” and “4” above. (Health & Safety Code 125290.30(f) (3) (B) and (C)).
    
6. Public Comment.
    
7. Adjournment.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9111 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 510-340-9111.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov

---